Key statistics
On Friday, Adaptive Biotechnologies Corp (ADPT:NSQ) closed at 10.39, -16.41% below its 52-week high of 12.43, set on Jun 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.66 |
---|---|
High | 10.77 |
Low | 10.25 |
Bid | 10.25 |
Offer | 10.40 |
Previous close | 10.50 |
Average volume | 1.81m |
---|---|
Shares outstanding | 151.92m |
Free float | 144.63m |
P/E (TTM) | -- |
Market cap | 1.60bn USD |
EPS (TTM) | -0.9592 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
More ▼
- Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
- Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
- Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
- Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
- Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
- Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
- Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
- Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
- Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
More ▼